Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs

Electroencephalogr Clin Neurophysiol. 1997 Dec;105(6):430-7. doi: 10.1016/s0924-980x(97)00050-7.


Transcranial magnetic stimulation was used to probe the acute effect of a single oral dose of various dopaminergic (levodopa, selegiline, bromocriptine) and antidopaminergic drugs (sulpiride, haloperidol) on motor cortex excitability in healthy volunteers. Motor threshold, intracortical inhibition and intracortical facilitation were tested in the abductor digiti minimi muscle. The latter two parameters were studied in a conditioning-test paired stimulus paradigm. The principal findings were an increase in intracortical inhibition by bromocriptine, and, conversely, a decrease in intracortical inhibition and an increase in intracortical facilitation by haloperidol. Effects peaked at delays consistent with the pharmacokinetics of the two drugs and were fully reversible. In conclusion, dopamine receptor agonists and antagonists can be considered inverse modulators of motor cortex excitability: the former enhance inhibition while the latter reduce it. The relation of the present findings to current models of motor excitability abnormalities in movement disorders will be discussed.

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Analysis of Variance
  • Bromocriptine / pharmacology
  • Dopamine Agonists / pharmacology*
  • Dopamine Antagonists / pharmacology*
  • Electromyography
  • Evoked Potentials, Motor / drug effects*
  • Female
  • Haloperidol / pharmacology
  • Humans
  • Levodopa / pharmacology
  • Magnetics
  • Male
  • Motor Cortex / drug effects*
  • Physical Stimulation
  • Reference Values
  • Selegiline / pharmacology
  • Sulpiride / pharmacology


  • Dopamine Agonists
  • Dopamine Antagonists
  • Selegiline
  • Bromocriptine
  • Levodopa
  • Sulpiride
  • Haloperidol